| Literature DB >> 18267971 |
R Lynn Sherrer1, Joanne M L Ho, Dieter Söll.
Abstract
Selenocysteine (Sec) biosynthesis in archaea and eukaryotes requires three steps: serylation of tRNA(Sec) by seryl-tRNA synthetase (SerRS), phosphorylation of Ser-tRNA(Sec) by O-phosphoseryl-tRNA(Sec) kinase (PSTK), and conversion of O-phosphoseryl-tRNA(Sec) (Sep-tRNA(Sec)) by Sep-tRNA:Sec-tRNA synthase (SepSecS) to Sec-tRNA(Sec). Although SerRS recognizes both tRNA(Sec) and tRNA(Ser) species, PSTK must discriminate Ser-tRNA(Sec) from Ser-tRNA(Ser). Based on a comparison of the sequences and secondary structures of archaeal tRNA(Sec) and tRNA(Ser), we introduced mutations into Methanococcus maripaludis tRNA(Sec) to investigate how Methanocaldococcus jannaschii PSTK distinguishes tRNA(Sec) from tRNA(Ser). Unlike eukaryotic PSTK, the archaeal enzyme was found to recognize the acceptor stem rather than the length and secondary structure of the D-stem. While the D-arm and T-loop provide minor identity elements, the acceptor stem base pairs G2-C71 and C3-G70 in tRNA(Sec) were crucial for discrimination from tRNA(Ser). Furthermore, the A5-U68 base pair in tRNA(Ser) has some antideterminant properties for PSTK. Transplantation of these identity elements into the tRNA(Ser)(UGA) scaffold resulted in phosphorylation of the chimeric Ser-tRNA. The chimera was able to stimulate the ATPase activity of PSTK albeit at a lower level than tRNA(Sec), whereas tRNA(Ser) did not. Additionally, the seryl moiety of Ser-tRNA(Sec) is not required for enzyme recognition, as PSTK efficiently phosphorylated Thr-tRNA(Sec).Entities:
Mesh:
Substances:
Year: 2008 PMID: 18267971 PMCID: PMC2330242 DOI: 10.1093/nar/gkn036
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971
Phosphorylation of tRNASec mutants by M. jannaschii PSTK
| tRNA | Base exchange or domain transplantation | Aminoacylation | Phosphorylation | Relative efficiency |
|---|---|---|---|---|
| Wild-type tRNASec | 80.3 ± 3.8 | 75.6 ± 3.8 | 100 | |
| Wild-type tRNASerUGA | 71.6 ± 8.1 | ND | – | |
| Acceptor stem | Acceptor stem + T arm | 20.1 ± 1.4 | 0.4 ± 0.1 | 2.1 |
| Δ 5a-67b (G-U) | 90.6 ± 0.3 | 87.0 ± 0.7 | 102.0 | |
| Δ 5b-67a (G-C) | 89.7 ± 0.9 | 85.8 ± 1.0 | 101.6 | |
| Δ 5a-67b and 5b-67a | 8.9 ± 0.4 | 4.6 ± 0.4 | 54.9 | |
| Δ G2-C71 | 73.4 ± 10.4 | 0.9 ± 0.3 | 1.3 | |
| G2-C71 →C-G | 63.4 ± 6.0 | 2.2 ± 0.3 | 3.7 | |
| →G-U | 75.6 ± 0.5 | 19.6 ± 1.4 | 27.5 | |
| →A-U | 47.2 ± 0.9 | 5.7 ± 1.6 | 12.8 | |
| →U-A | 35.3 ± 0.6 | 13.8 ± 2.7 | 41.5 | |
| C3-G70 →G-C | 64.7 ± 1.4 | 7.6 ± 1.1 | 12.5 | |
| →A-U | 58.3 ± 1.5 | 41.7 ± 1.7 | 75.9 | |
| →U-A | 70.6 ± 1.6 | 66.5 ± 1.5 | 100.0 | |
| →U-G | 66.1 ± 3.8 | 57.9 ± 4.6 | 93.0 | |
| C5-G68 →G-C | 41.6 ± 0.8 | 36.7 ± 0.9 | 93.7 | |
| →A-U | 65.6 ± 1.3 | 28.1 ± 0.7 | 45.5 | |
| →U-A | 50.6 ± 1.5 | 43.8 ± 1.3 | 91.9 | |
| →U-G | 61.3 ± 0.6 | 49.2 ± 4.7 | 85.3 | |
| D-arm | D-arm | 1.4 ± 0.4 | ND | – |
| U16→A | 25.1 ± 0.14 | 18.4 ± 0.1 | 77.9 | |
| U16→G | 48.7 ± 7.9 | 32.0 ± 6.0 | 69.8 | |
| C15→G | 79.7 ± 1.0 | 70.9 ± 3.9 | 94.5 | |
| U16→A/C15→G | 75.8 ± 2.1 | 57.6 ± 1.5 | 80.7 | |
| A20a→G | 56.6 ± 2.2 | 50.2 ± 1.3 | 94.2 | |
| A20a→U | 71.3 ± 10.1 | 43.9 ± 2.1 | 65.4 | |
| A20a→U/U16→A | 57.8 ± 1.2 | 55.7 ± 1.1 | 102.3 | |
| A20a→C | 69.9 ± 2.7 | 63.6 ± 2.2 | 96.6 | |
| Anticodon stem | Anticodon stem-loop | 46.5 ± 0.2 | 40.3 ± 1.2 | 92.1 |
| Anticodon | UCA→UGA | 84.9 ± 1.0 | 80.1 ± 0.4 | 100.2 |
| Variable arm | Variable arm | 52.8 ± 2.6 | 50.2 ± 2.5 | 101.0 |
| T-arm | T-arm | 37.9 ± 0.8 | 24.6 ± 1.9 | 68.9 |
| G50-C64 →C-G/G51-C63 →C-G | 52.6 ± 0.2 | 40.3 ± 1.2 | 81.4 | |
| T-loop | 44.9 ± 0.9 | 24.9 ± 6.0 | 58.9 | |
| G57→A | 74.2 ± 1.5 | 71.7 ± 0.9 | 102.6 | |
| U59→A | 70.2 ± 1.6 | 58.4 ± 4.3 | 88.4 | |
| 75.0 ± 0.5 | 65.3 ± 6.4 | 92.5 | ||
| Heterologous tRNASec | 50.4 ± 1.0 | 48.2 ± 0.9 | 101.6 | |
| 53.3 ± 2.4 | 7.0 ± 2.1 | 13.9 | ||
| 74.4 ± 3.1 | 12.8 ± 2.4 | 18.3 | ||
| Chimeric tRNA | Transplant 1 | 4.8 ± 0.3 | 0.0001 ± 0.0006 | 0.002 |
| Transplant 2 | 9.6 ± 0.7 | 4.3 ± 0.4 | 47.6 | |
| Transplant 3 | 17.7 ± 1.7 | 5.2 ± 0.7 | 31.2 | |
| Chimera | 18.9 ± 0.1 | 12.1 ± 1.1 | 68.0 |
atRNA transcripts were used.
bThe percent aminoacylation (serylation plus phosphorylation) refers to the intensity of the Ser-[32P]AMP and Sep-[32P]AMP spots divided by the total intensity of the Ser-[32P]AMP, Sep-[32P]AMP, and [32P]AMP spots and phosphorylation refers to the intensity of the Sep-[32P]AMP spot divided by the total intensity of the Ser-[32P]AMP, Sep-[32P]AMP, and [32P]AMP spots (See ‘Materials and Methods’ section).
cThe assay was performed on all tRNAs in triplicate and the standard deviations for each are reported.
dThe efficiency of phosphorylation was calculated by dividing the percent of tRNA phosphorylated by the percent total aminoacylation. The relative efficiency is a comparison of the efficiency of phosphorylation of each mutant tRNA to that of wild-type M. maripaludis tRNASec calculated by dividing the percent efficiency of phosphorylation of each mutant by that of wild-type M. maripaludis tRNASec multiplied by 100%.
eDomain from M. maripaludis tRNASerUGA was transplanted onto the M. maripaludis tRNASec backbone.
fND, Activity not detectable.
Figure 1.Conservation of archaeal tRNASec and tRNASer sequences and transplantation of tRNASec identity elements into tRNASer. The cloverleaf structures of M. maripaludis tRNASec (A) and tRNASerUGA (B) are shown. The secondary structures of presently available archaeal tRNASec (seven sequences) and tRNASer from Sec-decoding archaea (18 sequences) were compared (See Supplementary Figure 1). Bold and red nucleotides are invariant within each tRNASec or tRNASer. Bold and blue nucleotides are at least 70% conserved within each tRNASec or tRNASer. Blue nucleotides are at least 70% conserved within each tRNASec or tRNASer but not in the pictured M. maripaludis tRNAs. Gray shading shows residues conserved at >70% between tRNASec and tRNASer. Black boxes on G2-C71 and C3-G70 of tRNASec in (A) indicate identity elements transplanted into the tRNASer scaffold to produce the tRNA chimera pictured in (C). The black box on A5-U68 of tRNASer in (B) indicates an antideterminant that was mutated to C5-G68 in the tRNA chimera (C). The mutated nucleotides are boxed, bold and orange in the tRNA chimera. The numbering of tRNASec is according to Sturchler et al. (18), and the numbering of tRNASer is according to Sprinzl et al. (39).
Figure 2.In vitro conversion of Ser-tRNA to Sep-tRNA by M. jannaschii PSTK. One micromolar 32P-labeled Ser-tRNASec (70.8% serylated), chimera Ser-tRNA (64.5% serylated) or Ser-tRNASer (63.4% serylated) was incubated with 50 nM PSTK at 37°C for 15 min. Aliquots of the reactions were quenched with 100 mM sodium citrate, pH 5.0 and digested with 0.66 mg/ml nuclease P1 for 35 min at room temperature. Samples were then spotted onto a PEI-cellulose TLC plate and developed in 100 mM ammonium acetate, 5% acetic acid for 75 min. Following quantification of the intensities of Ser-[32P]AMP, [32P]AMP and Sep-[32P]AMP using ImageQuant, the fraction (%) of aminoacyl-tRNA formed at each time point was calculated by dividing the intensity of the Sep-[32P]AMP and Ser-[32P]AMP spots by the total intensity and the fraction (%) of Sep-tRNASec formed at each time point was calculated by dividing the intensity of the Sep-[32P]AMP spot by the total intensity. The phosphorylation efficiency was determined by dividing the percent Sep-tRNA by the percent aminoacyl-tRNA. Error bars represent the standard deviation of three separate experiments.
Figure 3.tRNASer chimera with transplanted (tRNASec) identity elements induces the ATPase activity of PSTK. A graph is shown of the ratio of [α-32P]ATP converted to [α-32P]ADP by PSTK (1 µM) in the presence of 1 µM tRNASec, chimera tRNA, G2-C71:C-G tRNASec mutant or tRNASer. The minimal ATPase activity in the absence of tRNA was subtracted. Error bars represent the standard deviation of three separate experiments.
Figure 4.Comparative alignment of archaeal, eukaryotic and bacterial tRNASec acceptor stems. The secondary structures of archaeal (seven sequences, Supplementary Figure 1), eukaryotic (57 sequences, Supplementary Figure 2) and bacterial tRNASec (50 sequences) were aligned. (A) Alignment of the acceptor stems of all presently known archaeal tRNASec and representative eukaryotic tRNASec are shown. Nucleotides are colored according to sequence similarity (BLOSUM 50) between the archaeal and eukaryotic tRNASec. Red asterisks indicate key nucleotides in the acceptor stem of archaeal tRNASec for phosphorylation by PSTK. (B) Alignment of the acceptor stems of representative bacterial tRNASec to those of the archaeal and eukaryotic tRNASec. Nucleotides are colored according to sequence similarity (BLOSUM 50) among the bacterial tRNASec.
Figure 5.In vitro conversion of threonyl-tRNASec to phosphothreonyl-tRNASec by PSTK. One micromolar 32P-labeled tRNASec transcript was incubated with 600 nM SerRS and Thr (lane 1), 600 nM SerRS, 100 nM PSTK and Thr (lane 2), 600 nM SerRS and Ser (lane 3), or 600 nM SerRS, 100 nM PSTK and Ser (lane 4) at 37°C for 45 min. Aliquots of the reactions were quenched with 100 mM sodium citrate, pH 5.0 and digested with 0.66 mg/ml nuclease P1 for 35 min at room temperature. Samples were then spotted onto a PEI-cellulose TLC plate and developed in 100 mM ammonium acetate, 5% acetic acid for 75 min.